SCHEMBL7017374

SCHEMBL7017374

C[C@](S)(CS)Cn1c(=O)[nH]c2ccccc2c1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.60
ALDH1A1 P00352 5/20 0.55
HPGD P15428 3/20 0.55
KDM4E B2RXH2 3/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MPO P05164 2/20 0.50
ADORA3 P0DMS8 1/20 0.49
ADORA2A P29274 1/20 0.49
ADORA2B P29275 1/20 0.49
ADORA1 P30542 1/20 0.49
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CA12 O43570 1/20 0.45
RNASEH1 O60930 1/20 0.45
ERCC1 P07992 1/20 0.45
ERCC5 P28715 1/20 0.45
FEN1 P39748 1/20 0.45
CA9 Q16790 1/20 0.45
ERCC4 Q92889 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11922973 0.84 CYP1A2 (0.69) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL5514563 0.80 CYP1A2 (0.63) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL7015737 0.79 FEN1 (0.50) CYP1A2ALDH1A1KDM4ESMN1; SMN2HSD17B10
SCHEMBL7014576 0.79 ADORA3 (0.41) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL7022190 0.79 ADORA3 (0.41) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL7015733 0.79 FEN1 (0.50) CYP1A2ALDH1A1KDM4ESMN1; SMN2HSD17B10
SCHEMBL6242682 0.78 CYP1A2 (0.64) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL7014473 0.77 TSHR (0.33) CYP1A2ALDH1A1TSHRKMT2AMEN1
SCHEMBL7014468 0.77 TSHR (0.33) CYP1A2ALDH1A1TSHRKMT2AMEN1
SCHEMBL1662185 0.76 ALDH1A1 (0.68) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003089416-A1 SUBSTITUTED PYRIMIDINE-2,4(1H,3H)-DIONES FOR USE AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS IBFB GMBH (DE) 2003-10-30 WO claimed
EP-1357114-A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP) IBFB GmbH Privates Institut für biomedizinische Forschung und Beratung (DE) 2003-10-29 EP claimed
WO-2003089416-A1 SUBSTITUTED PYRIMIDINE-2,4(1H,3H)-DIONES FOR USE AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS IBFB GMBH (DE) 2003-10-30 WO disclosed
EP-1357114-A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP) IBFB GmbH Privates Institut für biomedizinische Forschung und Beratung (DE) 2003-10-29 EP disclosed